Almost every LBO i've paid attention to (non-bio) was an excuse to plunder the company to reward those doing the LBO then leave the company a shell. Along the way shareholders got screwed big time.

There seems to be no large accumulation of shares suggesting an LBO. By the time any LBO was attempted it would take $2.2 -$4.6 billion to put together that 30% of shares. Then there's 100 million shares to stave it off. Not to mention under Delaware law those LBO shares would be non-voting for the purpose of a vote on a BO and a 2/3rd majority of other stockholders would have to approve.


What assets are there for an LBO team to leverage? The only thing of true value we have at this point is the intellectual property. Without an FDA approval that's rather weak to base a LBO on. On approval for COVID then it becomes IP and potential revenue. With revenue coming in do you think 2/3rds of existing shareholders would vote yes to leaving this a shell company that makes their shares virtually worthless?

NP has been very careful in not exposing the IP to potential seizure. The last thing we shareholders need is an LBO putting the IP at risk.